FR2918281B1 - MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE. - Google Patents

MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.

Info

Publication number
FR2918281B1
FR2918281B1 FR0706697A FR0706697A FR2918281B1 FR 2918281 B1 FR2918281 B1 FR 2918281B1 FR 0706697 A FR0706697 A FR 0706697A FR 0706697 A FR0706697 A FR 0706697A FR 2918281 B1 FR2918281 B1 FR 2918281B1
Authority
FR
France
Prior art keywords
parkinson
medicament
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0706697A
Other languages
French (fr)
Other versions
FR2918281A1 (en
Inventor
Andreas Hartmann
Anne Marie Bonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0706697A priority Critical patent/FR2918281B1/en
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to DK08827349.5T priority patent/DK2173366T3/en
Priority to ES08827349T priority patent/ES2421709T3/en
Priority to JP2010514040A priority patent/JP5517925B2/en
Priority to PT88273495T priority patent/PT2173366E/en
Priority to US12/667,471 priority patent/US8232249B2/en
Priority to PCT/FR2008/000937 priority patent/WO2009022067A2/en
Priority to EP08827349.5A priority patent/EP2173366B1/en
Publication of FR2918281A1 publication Critical patent/FR2918281A1/en
Application granted granted Critical
Publication of FR2918281B1 publication Critical patent/FR2918281B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0706697A 2007-07-02 2007-09-25 MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE. Active FR2918281B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0706697A FR2918281B1 (en) 2007-09-25 2007-09-25 MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.
ES08827349T ES2421709T3 (en) 2007-07-02 2008-07-01 Use of bee venom to treat Parkinson's disease
JP2010514040A JP5517925B2 (en) 2007-07-02 2008-07-01 Parkinson's disease treatment
PT88273495T PT2173366E (en) 2007-07-02 2008-07-01 Use of bee venom for treating parkinson's disease
DK08827349.5T DK2173366T3 (en) 2007-07-02 2008-07-01 USE OF BIGIFT TO TREAT PARKINSON'S DISEASE
US12/667,471 US8232249B2 (en) 2007-07-02 2008-07-01 Medicament for treating parkinson's disease
PCT/FR2008/000937 WO2009022067A2 (en) 2007-07-02 2008-07-01 Medicament for treating parkinson's disease
EP08827349.5A EP2173366B1 (en) 2007-07-02 2008-07-01 Use of bee venom for treating parkinson's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706697A FR2918281B1 (en) 2007-09-25 2007-09-25 MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.

Publications (2)

Publication Number Publication Date
FR2918281A1 FR2918281A1 (en) 2009-01-09
FR2918281B1 true FR2918281B1 (en) 2009-11-06

Family

ID=39079429

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0706697A Active FR2918281B1 (en) 2007-07-02 2007-09-25 MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.

Country Status (1)

Country Link
FR (1) FR2918281B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154887A1 (en) * 2010-06-07 2011-12-15 Assistance Publique - Hopitaux De Paris Mellitin for the use thereof in the treatment of parkinson's disease
FR2960780B1 (en) * 2010-06-07 2012-08-10 Assist Publ Hopitaux De Paris MEDICINE FOR THE TREATMENT OF PARKINSON'S DISEASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03505868A (en) * 1988-04-08 1991-12-19 マサチユセツツ・インスチチユート・オブ・テクノロジー Methods and compositions for treating neurological diseases

Also Published As

Publication number Publication date
FR2918281A1 (en) 2009-01-09

Similar Documents

Publication Publication Date Title
BRPI0818799A2 (en) Compositions for the treatment of parkinson's disease
BR112012002124A2 (en) treatment of crohn's disease with laquinimode.
DK2303330T4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE
ZA200909191B (en) Catecholamine derivatives useful for the treatment of parkinson's disease
EP2035412A4 (en) Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
IL206277A0 (en) 1,2,4-oxadiazole compounds for the treatment of autoimmune diseases
IL195431A0 (en) Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
EP2320939A4 (en) Tissue kallikrein for the treatment of parkinson's disease
FR2918282B1 (en) MEDICINE FOR THE TREATMENT OF PARKINSON'S DISEASE
PT2056804E (en) Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases
FR2906468B1 (en) USE OF COMPOUNDS OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
FR2933609B1 (en) USE OF INDOLE DERIVATIVES AS NURR-1 ACTIVATORS FOR THE TREATMENT OF PARKINSON'S DISEASE.
FR2905600B1 (en) TREATMENT OF VERTIGS BY ACETYL-L-LEUCINE.
FR2910324B1 (en) NEW MEDICINE FOR THE TREATMENT OF GASTRIC CANCER
FR2918281B1 (en) MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.
FR2924593B1 (en) BONE PLATE FOR THE TREATMENT OF THE LOWER END OF THE CUBITUS
FR2906469B1 (en) USE OF COMPOUNDS OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2912059B1 (en) USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE
FR2906467B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2906466B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2960780B1 (en) MEDICINE FOR THE TREATMENT OF PARKINSON'S DISEASE
EA200970970A1 (en) APPLICATION OF 4-CYCLOPROPILMETOXY-N- (3,5-DICHLOR-1-OXIDO-CLEAN-4-PYRIDIN-4-IL) -5- (METHOXI) -PYRIDIN-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS, CONNECTED CHAPTER-CHARACOXYLIDE
FR2926023B1 (en) USE OF A HOMOPROTEIN OF THE BICOID FAMILY FOR THE TREATMENT OF GLAUCOMA.
EP2174666A4 (en) Medicinal agent for prevention or treatment of alzheimer's disease
FR2872045B1 (en) MEDICAMENTS FOR THE SPECIFIC TREATMENT OF SYMPTOMS OF PARKINSON'S DISEASE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

CL Concession to grant licences

Name of requester: KEY NEUROSCIENCES, FR

Effective date: 20160322

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11